Helicobacter hepaticus (Hh) is a new type of Helicobacter associated with H. pylori, which can cause chronic hepatitis, and even lead to liver cancer in mice. Whether the Hh is the same with species separated from the mice has not been determined.
There are detailed study and much reports on bacteriology of H. pylori. Hh is a kind of Gramnegative spiral-shaped bacterium with 1-3 turns. It has different sizes, with length of 1.55 μm, width of 0.2-0.3 μm. Observed in electron microscope, the surface of Hh is smooth, and there is one scabbard flagella at each end of the bacteria, which make the bacteria have function of movement.
Hh is similar to H. pylori, which can produce urease, peroxidase, oxidase, reduction of nitride to nitrate, produce hydrogen sulfide (H 2 S) and hydrolyze indoleacetic acid. Hh requires high nutrition, so they are often inoculated in Columbia medium with 7% sheep blood, 10 g/L vancomycin, 2 g/L amphotericin B and 2.5 g/L polymyxin B. Cultured for 3-7 days at the microaerophilic environment (i.e. 85% N 2 , 10% CO 2 , 5% O 2 ) with high humidity and the condition of 37 ℃, transparent microcolonies with a diameter of 1 -2 mm will be observed, and there is no obvious hemolysis.
The defensive capability of the patients with cirrhosis to infection is reduced, which can cause endotoxemia and H. pylori proliferation in gastric mucosa, and H. pylori can also reach the liver through the bloodstream and cause hepatitis. The incidence of peptic ulcer, gastritis, especially atrophic gastritis in patients with chronic liver diseases is higher than that of non liver disease group. 14 H. pylori antibody prevalence rate between patients with autoimmune hepatitis (AIH) and the controls also had no significant differences (22% vs 14%). Another study found H. pylori seroprevalence increased in autoimmune liver diseases. The results showed that H. pullorum, Helicobacter Bilis and Hh positive rates were 30%, 22% and 22% in primary sclerosing cholangitis (PSC) patients with dot immunobinding assay, respectively. Seroprevalence was significantly higher in patients with chronic autoimmune liver diseases than in healthy blood donors (P < 0.001). Sustained liver cell necrosis is characteristic of autoimmune hepatitis, often progresses to cirrhosis. A case-control study found that H. pylori prevalence rate of patients with chronic autoimmune hepatitis and blood donors had no significant differences (64.5% vs 53.2%, P = 0.3).
Hh and liver diseases
Studies on relationship between Hh and liver are mostly carried in animal models. Uninfected mice took Hh standard strains of ATCC51448 orally, then scattered liver cell necrosis appeared in rat liver after 2 weeks. The necrosis aggravated at week 10-16, and reached the peak at week 28. One mouse had hepatoma. Another study found that liver cells of A/J Cr mice infected with Hh gradually increased in size, oval cell proliferated, and the focal nodular hyperplasia formated after 1 year. Pathological changes from chronic hepatitis to liver cancer were observed at week 78. Different Hh strains can cause different degrees of hepatitis because of different genetic composition changes. The A70Kb gene (HHGI1) island in strain ATCC 51449 is a pathogenic island (PAI). In order to determine the role of PAI in vivo, Boutin et al administrated Hh3B1 strains, one of the three inoculated Hh strains to mice, which contains the complete PAI, and strains HhNET and HhG lack all or large parts of the HHGI1, respectively. 15 Mice infected with HhG and HhNET developed less-severe hepatitis than the male A/J Cr mice infected with Hh3B1. Hh is considered as one of the causes of chronic hepatitis and hepatocellular carcinoma in mice. Pathogenesis of Hh includes host factors, oxidative damage, oncogene activation, and the abnormal expression of cyclins. With the aggravation of pathological changes in liver after Hh infection, 8-hydroxy deoxyguanosine (8-OXO-dG) significantly increased, which is a sensitive marker of oxidative damage. Using immunohistochemistry and Western blot to detect the liver pathological changes at different stages in A/JCr mice infected with Hh, researchers found that EGF, TGF-α increased in the early stage of disease, and were 8 times and 9 times of the control group, respectively. EGF significantly increased in tumor tissues, while cyclin D1 and CDK4 increased significantly in all the infected liver tissue. Their expression were 8 times and 50 times at 18 months, respectively, but the expression was highest in liver tumors. These changes suggested that the combined action of growth factor, cell cycle proteins, transcription factors play an important role in the pathogenesis of Hh related liver tumor. 1 In recent years, many scholars found that hepatitis C and Hh had a synergistic effect, which cause increased incidence of hepatocellular carcinoma. Hh can increase the liver injury. The presence of carcinoma is more likely to occur on a background of hepatitis C. Researches found that the effect of the mouse genetic background was greater than that of the HCV transgene, and the synergistic effect between HCV and Hh participated in hepatocellular carcinoma. 16 Hh promoting tumorigenesis is accompanied by increased bile acids and immune response. Androstane receptor (CAR) is a nuclear receptor that regulates enzymes involved in endobiotic and xenobiotic metabolism. CAR activation is a mechanism of xenobiotic tumor promotion. CAR knockout (KO) and wild-type (WT) male mice were treated with or without the tumor intiator diethylnitrosamine (DEN) at 5 weeks of age, and then orally inoculated with Hh or sterile media at 8 weeks of age. At approximately week 50 postinoculation, mice were euthanized for histopathologic, microbiological, molecular, and metabolic analyses 17 . 
PROSPECT
Helicobacter, especially H. pylori and Hh being associated with chronic liver disease has been achieved consensus. In recent years, case-control studies and animal models on the association of the Helicobacter and chronic liver diseases gradually increased. China is a liver disease prone country, and H. pylori high prevalence areas. Therefore, there's urgent need to strengthen the study on the role of inflammatory factors, immune factors, clinical pathology and molecular biology on the pathogenesis of chronic liver disease with Helicobacter infection, and clarify the pathogenesis and epidemiology, to reduce the incidence of chronic liver diseases and improve the diagnosis, treatment and prognosis of Helicobacter induced liver diseases.
